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Abstract
Background: Chlorpromazine (CPZ), a commonly used antipsychotic drug, was found to play a neuroprotective role in
various models of toxicity. However, whether CPZ has the potential to affect brain apoptosis in vivo is still unknown. The
purpose of this study was to investigate the potential effect of CPZ on the apoptosis induced by exogenous stimuli.
Methodology: The ethanol treated infant rat was utilized as a valid apoptotic model, which is commonly used and could
trigger robust apoptosis in brain tissue. Prior to the induction of apoptosis by subcutaneous injection of ethanol, 7-day-old
rats were treated with CPZ at several doses (5 mg/kg, 10 mg/kg and 20 mg/kg) by intraperitoneal injection. Apoptotic cells
in the brain were measured using TUNEL analysis, and the levels of cleaved caspase-3, cytochrome c, the pro-apoptotic
factor Bax and the anti-apoptotic factor Bcl-2 were assessed by immunostaining or western blot.
Findings: Compared to the group injected with ethanol only, the brains of the CPZ-pretreated rats had fewer apoptotic
cells, lower expression of cleaved caspase-3, cytochrome c and Bax, and higher expression of Bcl-2. These results
demonstrate that CPZ could prevent apoptosis in the brain by regulating the mitochondrial pathway.
Conclusions: CPZ exerts an inhibitory effect on apoptosis induced by ethanol in the rat brain, intimating that it may offer a
means of protecting nerve cells from apoptosis induced by exogenous stimuli.
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Introduction
Chlorpromazine (CPZ), a phenothiazine neuroleptic drug, has a
very wide range of applications in the treatment of psychosis, anti-
emesis and the induction of artificial hibernation [1]. Over the
years, the evidence regarding protective effects of CPZ on the
nervous system is supported by the in vitro and animal studies
reporting its beneficial effects in various models of toxicity,
including ischemia [2], b-amyloid protein-induced Ca
2+ uptake
[3], cyanide poisoning [4] and glutamate-induced neurotoxicity
[5]. Moreover, recent studies suggest that CPZ treatment leads to
a higher level of the anti-apoptotic factor Bcl-2 level in the
schizophrenic cortexes of treated subjects compared to antipsy-
chotic-naive subjects [6].
These findings suggest that, apart from its antagonistic actions
on dopamine receptors, CPZ may also play a role in the regulation
of apoptosis during the course of drug treatment. In the present
study, ethanol-treated seven-day-old rats were used as an apoptosis
model to determine the potential effect of CPZ on ethanol-induced
apoptosis in the brain by measuring the number of apoptotic cells
and the expression of apoptosis-related proteins of the mitochon-
drial pathway.
Materials and Methods
Ethics Statement
All animal procedures performed in this work followed
guidelines in accordance with the Regulations for the Adminis-
tration of Affairs Concerning Experimental Animals, and
approved by the animal care and welfare committee of Harbin
Medical University (Protocol number of Animal Experimental
Ethical Inspection 2009104).
Animals and treatment
Wistar rats were obtained from the Center for Laboratory
Animals, Harbin Medical University, China. All the animals were
housed in the departmental animal colony in a vivarium with a
controlled climate (temperature 22uC, 30% humidity) and a 12-h
light/dark cycle.
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(Shanghai Harvest Pharmaceutical CO., LTD., China) at various
doses (5 mg/kg, 10 mg/kg and 20 mg/kg). 24 h after CPZ
injection, rats were injected subcutaneously with 20% ethanol
diluted in saline solution, to a final dose of 5.0 g/kg body weight,
according to the method described by Ikonomidou [7]. The rats
were treated with CPZ at the beginning of postnatal day seven, and
were exposed to ethanol at the end of day seven. The rats in each
treatment group are of the same age. The rats were euthanized by
decapitation without anesthesia to avoid the contamination of
brain with chemicals. The rats were sacrificed at several time
points after ethanol exposure (4 h, 8 h, 12 h or 24 h). Saline
injections of equal volume were used as controls. Animals in
each litter were distributed into the following treatment groups:
saline control, ethanol, CPZ pretreatment + ethanol. In addition,
to determine the effect of CPZ on apoptosis-related protein
expression in the brain, the rats were injected intraperitoneally
with CPZ (10 mg/kg) once daily for two weeks or were given a
single injection of a high dosage (20 mg/kg). A total of 150 infant
rats were used for the entire study, and four to nine animals from
different litters were used for each data point.
TUNEL assay
Terminal deoxynucleotidyl transferase-mediated dUTP nick
end-labeling (TUNEL) was performed at 24 h after ethanol
treatment. Rat brain samples were fixed, dehydrated, embedded
in paraffin, and sectioned into 4-mm slices prior to TUNEL and
immunohistochemical staining. To detect apoptotic cells, the
TUNEL reaction mixture was applied to the paraffin sections
using an in situ cell death detection kit POD (Roche, Germany) as
described by the manufacturer. After deparaffinization, the
sections were treated with 20 mg/ml proteinase K for 10 min.
After treatment with 0.3% H2O2 in methanol for 10 min, the
sections were incubated with the TUNEL reaction mixture for
60 min at 37uC. Further incubation with peroxidase-conjugated
antibody was performed for 30 min at 37uC. The sections were
stained with diaminobenzidine (DAB) solution for 10 min at room
temperature and then counterstained with hematoxylin. For
negative controls, the TUNEL reaction mixture was omitted,
and the same staining procedures were followed.
The sections were then visualized using a microscope (CX31,
Olympus, Japan), and digital photographs were taken with a
camera (MicroPublisherTM 5.0 RTV, Olympus, Japan). For each
group, all of the apoptotic cells throughout the whole cortex and
the hippocampus were counted under the microscope. Follow the
example of microscope counting chamber; we marked the slides
with grid lines to separate the section into many small squares.
Total numbers of the TUNEL-positive cells were counted under
the microscope with a hand-held counter. The cells touching the
middle line were counted on the top and left of the squares but not
on the bottom or right side (Figure S1). A total of 99 sections were
analyzed for TUNEL assay.
Immunohistochemistry (IHC)
Cleaved caspase-3 and cytochrome c expression were detected
in rat brains by IHC. IHC of cleaved caspase-3 was performed at
12 h after ethanol exposure, and IHC of cytochrome c was
performed at 8 h after ethanol exposure. Briefly, after hydration,
the sections were rinsed in PBS, quenched for 10 min in methanol
containing 3% H2O2, and incubated for 15 min in blocking
solution [PBS containing 2% goat serum, 0.2% milk, and 0.1%
Triton X-100], followed by incubation overnight in primary
antibodies against cleaved caspase-3 (#9661, Cell Signaling
Technology, Inc., MA, USA) and cytochrome c (sc-13156, Santa
Cruz Biotechnology Inc., CA, USA), diluted 1:50 in blocking
solution. After rinsing with PBS, the sections were incubated for
60 min in mouse or rabbit two-step histostaining reagent, which
was used as the secondary antibody. A DAB substrate kit for
peroxidase was then used to stain sections as described in the
manufacturer’s instructions. The secondary antibody and DAB
were purchased from Zhongshan Golden Bridge Biotechnology
CO., LTD., Beijing, China (PV-6001, PV-6002 and ZLI-9032).
The sections were counterstained with hematoxylin.
Scoring of cleaved caspase-3
The immunoreactive cells show different signal intensity which
is dependent on the expression level of cleaved caspase-3, and the
cleaved caspase-3 immunostaining signals in CPZ pretreatment
groups showed a scattered and uneven distribution. To avoid
the subjective error caused by selecting campus visualis, we choose
the SI (staining intensity) scoring method to quantify the positive
staining signals throughout the whole cortex and hippocampus.
The intensity of staining was scored as negative=SI0, weak=
SI1, intermediate=SI2, or strong=SI3, correlating to absence of
brown (that is, blue counterstain only), light brown, brown or dark
brown staining, respectively (Figure S2). For assessment of
immunohistochemical staining, the presence of any immunola-
beled cells was considered to represent positive caspase-3 expre-
ssion [8]. Total scores were calculated based on the SI using the
following formula [9]: Total Scores=16n (SI1) +26n (SI2) +36n
(SI3). A total of 81 sections were analyzed for cleaved caspase-3
immunostaining.
Quantification of cytochrome c expression
For IHC detection of cytochrome c, the parietal cortex, CA1 of
hippocampus and the thalamus were measured. The Area and
IOD (integrated optical density) of cytochrome c were analyzed
with Image-Pro plus 6.0, each specimen was measured randomly
in 5 visual fields at a 6400 magnification, and the average mean
density was calculated for each sample according to the formula:
Mean Density=IOD/Area. A total of 54 sections were analyzed
for cytochrome c immunostaining.
Semi-quantitative western blot analysis
The brain sample of each rat used for western blot was taken
from the whole brain. After euthanasia, tissue samples from the
whole brain were rapidly dissected out and sonicated in lysis buffer
(#P-0013, Beyotime Institute of Biotechnology. Shanghai, China)
with phenylmethanesulfonyl fluoride (PMSF, #ST506, Beyotime
Institute of Biotechnology. Shanghai, China). The samples were
lysed on ice for 30 min and then centrifuged for 20 min at
12,0006g( 4 uC), and the supernatants were aspirated and stored at
280uC until further use. The supernatants were assayed for total
protein using the bicinchoninic acid method (Enhanced BCA
Protein Assay Kit, #P0010S, Beyotime Institute of Biotechnology.
Shanghai, China).
Samples were resolved on 12% (actin, Bcl-2) or 15% (cleaved
caspase-3, Bax, cytochrome c) Tris-glycine polyacrylamide gels
using a Mini-Protean Tetra Electrophoresis System (Bio-Rad,
Hercules, CA, USA). Equal amounts of total protein were boiled
for 5 minutes in sodium dodecyl sulfate gel-loading buffer and
applied to the gels. All gels were run with a low-range molecular
weight ladder (PageRuler
TM Prestained Protein Ladder, Fermen-
tas, USA), and proteins were transferred to a nitrocellulose
membrane (Millipore, Billerica, MA, USA) in a BioRad Trans-
Blot SD Semi-Dry Transfer Unit. Blots were blocked with non-fat
dry milk in TBS-T (10 mM Tris, 150 mM NaCl, pH 7.6, plus
0.1% Tween-20) and probed with primary antibodies as follows:
Chlorpromazine Protects Against Apoptosis
PLoS ONE | www.plosone.org 2 July 2011 | Volume 6 | Issue 7 | e21966rat polyclonal anti-cleaved caspase-3 antibody (#9661, 1:1000,
Cell Signaling Technology, Inc., MA, USA), which recognizes the
17 kDa cleavage product, rat polyclonal Bax antibody (sc-483,
1:500, Santa Cruz Biotechnology Inc., CA, USA), mouse
monoclonal Bcl-2 antibody (sc-7382, 1:500, Santa Cruz Biotech-
nology Inc., CA, USA), mouse monoclonal cytochrome c
antibody, (sc-13156, 1:1000, Santa Cruz Biotechnology Inc.,
CA, USA). The immunoblots were processed with peroxidase-
conjugated anti-rabbit or anti-mouse antibodies (ZB-2305, ZB-
2301, 1:2000, Zhongshan Golden Bridge Biotechnology CO.,
LTD., Beijing, China), and peroxidase activity was detected using
the Pierce ECL Western Blotting Substrate (#32106, Thermo
Fisher Scientific Inc., USA).
For densitometric analysis, immunoreactive bands were scanned
with a Luminescent Imaging Analyzer (LAS-4000, Fuji, Japan) and
were quantified using Multi Gauge software (Fuji, Japan). A
monoclonal antibody against b-actin (sc-47778, 1:1000, Santa Cruz
Biotechnology Inc., CA, USA) was used as an internal control.
Statistical analysis
All values are expressed as the mean 6 SEM (standard error of
the mean). Statistical analysis was performed using SPSS 11.0.
Student’s t-test was used to evaluate differences between two
groups. Levene’s test was used to assess the variance homogeneity
(sig.0.05, homoscedasticity; sig,0.05, heteroscedasticity). One-
way analysis of variance (ANOVA) was used to compare the
differences between control and treatment groups, and Bonferro-
ni’s post hoc test was used for multiple comparison analysis if the
variance was homoscedastic. The non-parametric Mann-Whitney
U test was performed to assess the differences between treatment
groups if the variance was heteroscedastic. Differences with P
values,0.05 were regarded as statistically significant.
Results
CPZ pretreatment suppresses the apoptosis induced by
ethanol in rat brains
We observed that rats treated with CPZ before ethanol
administration showed a dramatic reduction of apoptosis in the
parietal cortex and CA1 of hippocampus even when CPZ was
administrated at a low dose (Figure 1B, C). Quantification of the
number of TUNEL-positive cells throughout the whole cortex and
the hippocampus showed that the apoptotic cells in ethanol group
(cortex: 217.3616.9; hippocampus: 60.0611.1) are much more
than saline group (cortex: 21.166.3; hippocampus: 13.064.1), and
the administration of CPZ reduced the number of cells undergoing
apoptosis caused by ethanol exposure (Figure 1D, Mann-Whitney
U test, p,0.05; n=6-9 animals per group). Data showed that in
the cortex, there was a significant decrease in the number of
TUNEL-positive cells in the CPZ pretreatment group at 10 mg/
kg (cortex: 31.663.7; hippocampus: 21.864.3) and 20 mg/kg
(cortex: 25.3167.6; hippocampus: 15.362.5) doses compared with
the 5 mg/kg dose (cortex: 46.5612.0; hippocampus: 31.066.8)
(P,0.05). In the hippocampus, CPZ (20 mg/kg) inhibited
apoptosis more strongly than did the 10 mg/kg and 5 mg/kg
doses (P,0.05). The results suggest that CPZ exerts a dose-
dependent protective effect against the ethanol-induced apoptosis
in both the whole cortex and hippocampus. Similar results were
obtained in thalamus (Figure S3) showing that the ethanol-induced
apoptosis (ethanol group: 154.3620.7) could be significantly
reduced by the pretreatment of CPZ at three different doses
(Mann-Whitney U test, p,0.001; n=6–9 animals per group;
5 mg/kg group: 31.367.4, 10 mg/kg group: 21.466.4, 20 mg/kg
group: 21.365.7).
CPZ pretreatment reduces high expression of cleaved
caspase-3 induced by ethanol in rat brains
Cleaved caspase-3 is an executioner leading to apoptosis, and
often used as a marker of apoptosis [10]. Western blot and IHC
were performed to determine whether inhibition of caspase-3
activation by CPZ is sufficient to prevent the apoptosis. Results
showed that cleaved caspase-3 was localized in cytoplasm and
nuclei with brown staining (Figure 2B). The immunoreactivity of
cleaved caspase-3 is specifically expressed in the apoptotic cells;
and the intensity of staining depends on the expression level of
cleaved caspase-3. A significant reduction of cleaved caspase-3
immunoreactive cells was found in rats treated with CPZ before
ethanol administration by scoring quantitative method. The
ethanol stimuli mediated a dramatic high immunohistochemical
scores in the ethanol group (cortex: 165.2 6 33.2; hippocampus:
61.2616.5), and a clear reduction of cleaved caspase-3 expression
in both the whole cortex (Bonferroni’s post hoc test, P,0.001;
n=5-7 animals per group) and hippocampus (Mann-Whitney U
test, P,0.05; n=5-7 animals per group) of the CPZ pretreatment
groups (5 mg/kg: cortex 49.0610.2, hippocampus 14.465.4;
10 mg/kg: cortex 36.0611.2, hippocampus 9.862.1; 20 mg/kg:
cortex 31.867.7, hippocampus 15.563.8) were corroborated
through the quantitative analysis (Figure 2C).
Meanwhile, the expression of cleaved caspase-3 was measured
by western blot using protein extracted from the whole brain of
rats in each treatment group. A representative western blot
depicting cleaved caspase-3 expression is shown in Figure 2D, and
this blot shows proteins from groups sacrificed 12 h after ethanol
exposure. The bands mainly represent the cleaved form of
17 kDa, and CPZ pretreatment significantly reduces the ethanol
induced high expression of cleaved caspase-3 without any effect on
the cleaved caspase-3 level at the high dose of 20 mg/kg.
Densitometric quantification of the bands indicated that animals
injected with ethanol alone showed a dramatic increase in cleaved
caspase-3 compared with the saline control (Mann-Whitney U test,
P,0.001; n=4 animals per group). CPZ pretreatment resulted in
a 5- to 10-fold dose-dependent decrease in cleaved caspase-3
expression compared with the group injected with ethanol alone
(Figure 2D, Mann-Whitney U test, P,0.001); maximum inhibi-
tion was observed at 20 mg/kg CPZ. CPZ prevented ethanol-
induced activation of caspase-3 at all time points tested, and at
12 h after ethanol injection, both the 10 mg/kg and the 20 mg/kg
doses resulted in stronger inhibition than the 5 mg/kg dose
(Figure 2D). A curve showing the dynamic effect of CPZ on
activation of caspase-3 revealed that cleaved caspase-3 appeared
4 h after ethanol administration, peaked at 8 h, and was still
evident after 24 h (Figure 2E). The results suggest that the ethanol
induced high expression of cleaved caspase-3 could be significantly
reduced by CPZ, and this finding confirmed the result obtained by
TUNEL assay.
CPZ pretreatment inhibits cytochrome c release in rat
brains
Most apoptotic cell death, including ethanol-induced apoptosis,
is dependent on the mitochondrial pathway, which includes
regulation of Bax and release of cytochrome c from mitochondria
[11]. This in turn activates caspase-3 and induces apoptosis
[12,13]. Therefore, to test whether cytochrome c is involved in the
effects of CPZ, cytochrome c protein levels were detected by IHC
(Figure 3B, C) and western blot (Figure 3D).
Based on previous studies, we selected the 8 h time point and
the dose of 20 mg/kg as the most appropriate time point and
concentration for the study of cytochrome c. Cytochrome c-
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PLoS ONE | www.plosone.org 3 July 2011 | Volume 6 | Issue 7 | e21966Figure 1. CPZ pretreatment reduces the number of apoptotic cells in rat brains after ethanol exposure. (A) The diagram shows the cross
section of the brain tissue, and the regions of the parietal cortex and CA1 of hippocampus are pointed out. (B and C) TUNEL-labeled brain sections
showing regions including the parietal cortex and the CA1 region of the hippocampus (stratum pyramidale). These brain sections were obtained from
the following treatment groups: Saline (a, a’, f and f’), Ethanol (b, b’, g and g’), and CPZ pretreatment at doses of 5 mg/kg (c, c’), 10 mg/kg (d, d’) and
20 mg/kg (e, e’, h and h’). The apoptotic cells with brown nuclear staining could be observed in the ethanol group and CPZ pretreatment + ethanol
groups. Sections were counterstained with hematoxylin. (D) The total number of apoptotic cells throughout the whole cortex and the hippocampus
of each specimen were counted in three separate experiments. Values are shown as means 6 SEM. A Mann-Whitney U test for multiple comparisons
revealed a significant difference between the ethanol treatment group and all other groups (**P,0.01, *P,0.05, n=6–9 animals per group).
doi:10.1371/journal.pone.0021966.g001
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PLoS ONE | www.plosone.org 4 July 2011 | Volume 6 | Issue 7 | e21966Figure 2. CPZ pretreatment inhibits cleaved caspase-3 expression in rat brains after ethanol exposure. (A) The diagram shows the cross
section of the cerebrum, and the regions of the parietal cortex and CA1 of hippocampus are pointed out. (B) Cleaved caspase-3 labeling corresponds
to brown staining could be observed in the cytoplasm and nuclei. Sections were counterstained with hematoxylin. (C) Total scores for cleaved
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(Figure 3B). Intense staining was detected in parietal cortex, CA1
of hippocampus and thalamus of the ethanol group, and weaker
staining was seen in the saline group and the CPZ pretreatment
group (Figure 3B). The expression of cytochrome c could be
clearly observed at thalamus as shown in high magnification
images (Figure 3B). Quantification of the data (Figure 3C) showed
that the mean density of cytochrome c immunostaining in ethanol
group (cortex: 11.761.8; hippocampus: 13.763.4; thalamus:
20.163.5) is much higher than saline control (cortex: 4.360.6;
hippocampus: 3.760.8; thalamus: 1.560.4), and the cytochrome c
expression in the CPZ pretreatment group (cortex: 8.161.3;
hippocampus: 3.561.0; thalamus: 6.962.0) was significantly lower
compared to the ethanol group in regions of the parietal cortex
Figure 3. CPZ pretreatment blocks the release of cytochrome c in rat brains after ethanol exposure. (A) The diagram shows the cross
section of the cerebrum, and the regions of the parietal cortex, CA1 of hippocampus and the thalamus are pointed out. (B) IHC examination of
cytochrome c levels in parietal cortex, CA1 of hippocampus and thalamus of the saline control (a, d, g and g’), ethanol-treated (b, e, h and h’), and CPZ
pretreatment groups (c, f, i and i’). Cytochrome c positive-immunoreactivity (brown) was located in the cytoplasm, and the inhibitory effect of CPZ on
ethanol-induced cytochrome c release is clearly shown in the high magnification photos (g’, h’ and i’). Sections were counterstained with
hematoxylin. (C) Densitometric quantification of the data yielded means 6 SEM. In the parietal cortex (***P,0.001; n=6 animals per group), CA1 of
hippocampus and thalamus (**P,0.01; n=6 animals per group), much more cytochrome c was released in the ethanol-treated group than in the
saline control group. In the parietal cortex (*P,0.05; n=6 animals per group), CA1 of hippocampus and thalamus (**P,0.01; n=6 animals per
group), the cytochrome c staining was significantly reduced in the CPZ pretreatment group compared with the group treated with ethanol. (D)
Western blot analysis of cytochrome c release from the isolated cytosolic fractions of the whole brain 8 h after ethanol administration. b-actin was
used as a loading control. Bands were measured using optical densitometry, and the data were normalized to a control sample (defined as 1.00).
Values are shown as means 6 SEM. The data indicate that CPZ pretreatment resulted in lower cytochrome c expression than that in the group
injected with ethanol alone (**P,0.01; n=4 animals per group).
doi:10.1371/journal.pone.0021966.g003
caspase-3 immunoreactivity were calculated, and all three doses of CPZ pretreatment significantly reduce cleaved caspase-3 expression in the
following regions, compared with the ethanol group: cortex (***P,0.001; n=5–7 animals per group) and hippocampus (*P,0.05; n=5–7 animals per
group). (D) The level of cleaved caspase-3 was analyzed by western blot from the whole brain taken 12 h after ethanol administration. b-actin was
used as a loading control. Cleaved caspase-3 bands were measured using optical densitometry, and the data were normalized to a control sample
(defined as 1.00). Values are shown as means6SEM. Mann-Whitney U test revealed a significant difference between the ethanol group and the CPZ
pretreatment groups (***P,0.001, *P,0.05, n=4 animals per group). (E) The curves show cleaved caspase-3 levels in the ethanol and CPZ
pretreatment groups at different time points (4 h, 8 h, 12 h and 24 h) after ethanol exposure. All three doses of CPZ result in a significant decrease of
the cleaved caspase-3 levels compared with ethanol group.
doi:10.1371/journal.pone.0021966.g002
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of hippocampus and thalamus (Mann-Whitney U test, P,0.01;
n=6 animals per group).
A western blot was performed to determine the inhibitory effect
of CPZ on cytochrome c release. Isolated cytosolic fractions from
the whole brain were prepared according to a previously described
method [14]. Quantification of the western blot indicated that a
substantial release of cytochrome c occurred at 8 h after ethanol
treatment (Figure 3D). Ethanol increased cytochrome c release
over the saline control (Mann-Whitney U test, P,0.01; n=4
animals per group). Importantly, CPZ pretreatment caused a
significant decrease in cytochrome c release compared with
ethanol alone (Mann-Whitney U test, P,0.01; n=4 animals per
group), and the level of cytochrome c declined to approximately
the same amount as that in the saline control. The results of
cytochrome c detection further confirmed the anti-apoptosis effect
of CPZ, intimating that the action of CPZ might be exerted via the
mitochondrial apoptosis pathway.
CPZ elevates levels of the anti-apoptotic protein Bcl-2
and inhibits the increase in the Bax/Bcl-2
At the mitochondrial level, the Bcl-2 family of proteins is
integral to the balance between pro-apoptotic and anti-apoptotic
signaling [15], and it has been implicated in ethanol-induced
apoptosis in the prenatal and neonatal developing brain [11]. In
order to determine if CPZ influences the ratio between Bax and
Bcl-2, which is one of the most important indices of apoptosis
mediated through the intrinsic mitochondrial mechanism [16],
three experiments were performed.
Firstly,ratswerepretreated withCPZ(at 5 mg/kg,10 mg/kg and
20 mg/kg) 24 h before ethanol exposure and sacrificed at 8 h after
ethanol injection. Quantification of the data (Figure 4A) showed that
the Bax/Bcl-2 ratio was significantly higher at 8 h after the ethanol
treatmentthaninthesaline-treatedcontrolgroup(Mann-WhitneyU
test, P,0.01; n=4 animals per group) and that all of the doses of
CPZ significantly decreased the Bax/Bcl-2 ratio compared with the
group treated with ethanol only (Mann-Whitney U test, P,0.001;
n=4 animals per group). In addition, both the 10 mg/kg and
20 mg/kgdoses decreased the Bax/Bcl-2 ratio morethan the5 mg/
kg dose did (P,0.001; n=4 animals per group), and the 20 mg/kg
dose had the strongest suppressive effect (P,0.05; n=4 animals per
group). The data show that the effectof CPZ on the ethanol-induced
increase in the Bax/Bcl-2 ratio is dose dependent.
Secondly, rats were intraperitoneally injected with a single
injection of CPZ at three different doses (5 mg/kg, 10 mg/kg and
20 mg/kg) and euthanized 24 h later. Western blot analysis
showed a substantial increase in the level of Bcl-2 upon treatment
with CPZ at 20 mg/kg (Figure 4B). Additionally, all three CPZ
doses significantly decreased the Bax/Bcl-2 ratio (Mann-Whitney
U test, P,0.01; n=4 animals per group), and the 20 mg/kg dose
was more effective at decreasing the Bax/Bcl-2 ratio than the
other two doses (P,0.001; n=4 animals per group).
Finally, CPZ (10 mg/kg/d, two weeks) was intraperitoneally
injected into rats continuously. The control animals were given an
equal volume of saline. The results showed an increase in Bcl-2
and a decrease in Bax expression (Figure 4C) in the CPZ-treated
group. The quantitated data (Figure 4C) indicated that the Bax/
Bcl-2 ratio was significant lower in the group continuously treated
with CPZ than in the saline control (Student’s t-test, p,0.001;
n=4 animals per group).
The results for chronic and acute treatment of CPZ suggest that
both the continuous use and the single use of CPZ could protect
against the ethanol-induced apoptosis by leading the upregulation
of anti-apoptotic Bcl-2 expression and the downregulation of Bax/
Bcl-2 ratio. Significant regulatory actions on the Bax/Bcl-2 ratio
could be mediated by the high dose (20 mg/kg) of CPZ acute
treatment and the medium (10 mg/kg) dose of CPZ chronic
treatment.
Figure 4. The effect of CPZ on the Bax/Bcl-2 ratio in rat brains after ethanol exposure. (A) CPZ treatment prior to ethanol exposure. The
level of Bax and Bcl-2 were analyzed in the whole brain taken 8 h after ethanol administration. The Bax/Bcl-2 ratio was more strongly increased at 8 h
after ethanol treatment compared to the saline control (**P,0.01; n=4 animals per group), and pretreatment with CPZ at various doses significantly
decreased the Bax/Bcl-2 ratio (***P,0.001; n=4 animals per group). Three independent experiments were performed, and a representative blot is
shown. b-actin was used as a loading control. Data are expressed as means 6 SEM. (B) Single injection of CPZ. The level of Bcl-2 was examined at 24 h
after a single injection of CPZ at 20 mg/kg. Groups treated with all three different doses of CPZ showed a significant decrease in the Bax/Bcl-2 ratio
compared with the saline control (**P,0.01; n=4 animals per group). In addition, the 20 mg/kg dose was the most effective at decreasing the Bax/
Bcl-2 ratio (***P,0.001; n=4 animals per group). Values are shown as means 6 SEM. (C) Continuous injection of CPZ. An increase in Bcl-2
accompanied by a decrease in Bax expression was detected after continuous treatment with CPZ. Values are shown as means 6 SEM. Quantification
of the data showed that the Bax/Bcl-2 ratio in the group continuously injected with CPZ was significantly lower than that in the saline control
(***P,0.001; n=4 animals per group).
doi:10.1371/journal.pone.0021966.g004
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Over the years, the evidence regarding neuroprotection of CPZ
is supported by in vitro and in vivo studies reporting its beneficial
effects in various models of toxicity. It has been reported that CPZ
play a dose-dependent neuroprotective effect on the ischemic
spinal cord of rabbits [2]. CPZ has also been shown to reduce
toxicity and Ca
2+ uptake induced by b-amyloid protein in primary
cultures of rat cortical neurons and PC12 cells [3], and protect
against the cyanide-induced neurotoxicity and glutamate-induced
neurotoxicity [4,5]. In addition, a previous study showed that
various atypical antipsychotics including CPZ exert a neuropro-
tective role against the cytotoxicity and primary hippocampal
neuronal cell death induced by growth medium deprivation
possibly through a caspase-dependent mechanism.[17]. However,
the influence of CPZ on brain apoptosis is still unclear.
In this study, the data demonstrate that CPZ was able to protect
the rat brain against the increase of apoptosis induced by ethanol.
Using a TUNEL assay, we demonstrated that administration of
CPZ prior to ethanol treatment can protect nerve cells against
ethanol-induced apoptosis in vivo. The results obtained by IHC and
western blot show that CPZ pretreatment leads to a lower
expression of cleaved caspase-3, cytochrome c Bax, and higher
expression of Bcl-2 compared to the group injected with ethanol
only, suggesting that CPZ could prevent apoptosis in the brain by
regulating the mitochondrial pathway. In order to evaluate
the action of CPZ on the ethanol-induced apoptosis in the rat
brain more comprehensive and accurate, a regional study was
performed and we determined the neuroprotective effect of CPZ
against ethanol induced-apoptosis in different brain regions
(cortex, hippocampus and thalamus) of immature rats. The results
demonstrated that the inhibitory actions of CPZ on the apoptosis
in these three regions are uniform. We also performed the
experiment to study the effect of CPZ on apoptosis by treating the
rats with CPZ after ethanol stimuli, but no significant changes
were found in the number of apoptotic cells by TUNEL assay. It
might be due to the reason that the apoptotic nerve cells caused by
ethanol treatment could be cleared by phagocytes within 72 h
[18]. Therefore, in the current study, the rats were treated with
CPZ before ethanol exposure to determine the effect of CPZ
pretreatment on the occurrence of apoptosis.
It has been previously revealed that CPZ mediates an
inhibitory effect on the hepatocyte apoptosis induced by the
cessation of phenobarbital (Phe) treatment in mice [19], and
CPZ has also been demonstrated to exert a protective role on
hepatocyte apoptosis caused by D-galactosamine both in
C57BL/6N Crj male mice and in cultured hepatocytes [20].
However, CPZ selectively increased cytotoxicity and induced
apoptosis in leukemic cells but had no effect on the viability of
normal lymphocytes or freshly isolated peripheral blood
mononuclear cells [21,22], suggesting that the influence of
CPZ on apoptosis is cell type dependent.
It has been reported that the ethanol, could trigger much more
apoptosis than could other pro-apoptotic agents (such as NMDA
antagonists or GABA mimetics) [7]. Therefore we used seven-day-
old rats injected with ethanol as a valid model of apoptosis to
investigate the effect of CPZ on apoptosis in the developing rat
brain. A previous study suggest that ethanol affects apoptosis in the
cell differentiation and migration zones of the prenatal rat brain by
modulating the mitochondrial apoptosis pathway [23].
Therefore, to clarify the mechanism involved in the protective
effect of CPZ, we examined the levels of important proteins in the
mitochondrial apoptosis pathway, including cleaved caspase-3,
cytochrome c, Bax and Bcl-2. IHC and western blot analysis
showed that CPZ blocks ethanol-induced cytochrome c release
and the ensuing caspase-3 activation. Bcl-2 is a potent inhibitor of
apoptosis, and cells that overexpress Bcl-2 demonstrate resistance
to a variety of pro-apoptotic insults [24]. Interestingly, we found
that the Bcl-2 level was increased in the brain of rats injected with
CPZ either once in isolation or continuously for two weeks, which
is consistent with previously published data indicating that antip-
sychotic treatment can raise cortical Bcl-2 levels in schizophrenic
patients [6]. The Bax/Bcl-2 ratio is an important determinant of
cytochrome c release from mitochondria in response to apoptotic
stimuli; a high Bax/Bcl-2 ratio promotes cytochrome c release
while low ratios inhibit release, and release of cytochrome c in turn
activates caspase proteins. The Bax/Bcl-2 ratio appears more
important than the Bax or Bcl-2 level alone in determining a cell’s
vulnerability to apoptosis; high Bax/Bcl-2 ratios lead to more
apoptosis [25]. In this study, we found that ethanol exposure
increased the Bax/Bcl-2 ratio in the developing rat brain; this
result is consistent with previous findings [23,26]. Our study
demonstrated that pretreatment with CPZ attenuated the increase
in the Bax/Bcl-2 ratio caused by ethanol; and that Bax/Bcl-2
ratios were significantly decreased in groups treated with CPZ in a
single injection or continuously for two weeks. The chronic as well
as the acute treatment of CPZ could inhibit the ethanol-induced
apoptosis by decreasing the Bax/Bcl-2 ratio, and the inhibitory
effect of chronic medium dose (10 mg/kg) CPZ treatment is
similar to the acute high dose (20 g/kg) treatment. These data
regarding the Bax/Bcl-2 ratio definitely support the results of the
TUNEL assay. Based on these results, we concluded that CPZ
pretreatment could protect against ethanol-induced apoptosis by
regulating the mitochondrial pathway.
In addition, studies have shown that many agents exert
neuroprotective effects through D2 receptors in a number of
model systems, including the apoptosis of hippocampal neurons
caused by transient ischemia [27], the PC12 cell apoptosis induced
by H2O2 or trophic withdrawal [28], and glutamate neurotrans-
mission and excitotoxicity [29]. In particular, CPZ, as a kind of
antipsychotic drugs with high affinity for the dopamine D2 and D4
receptor subtypes, has been shown to exert a neuroprotective role
against the cytotoxicity and primary hippocampal neuronal cell
death induced by growth medium deprivation [17]. Furthermore,
haloperidol has also been found to block the dopamine-mediated
apoptosis in pituitary tumor cell lines by its antagonistic function
on D2 receptors [30]. For the reason that CPZ acts primarily to
block D2 receptors, we speculate that the neuroprotective effect of
CPZ against ethanol-induced apoptosis might be D2 receptor
dependent.
CPZ is on the World Health Organization (WHO) list of
essential drugs and remains one of the drugs that are most
commonly used to treat schizophrenia [31]. In addition to the
dopamine hypothesis, investigators have also hypothesized that
apoptosis may play a role in the pathophysiology of schizophrenia,
[32–34]. Although it is still unknown whether or not the apoptosis
is a cause or a result of schizophrenia, the previous study suggest
that antipsychotic treatment can raise the anti-apoptotic factor
Bcl-2 level in the schizophrenic cortexes of treated subjects
compared to antipsychotic-naive subjects [6]. The leading hypo-
thesis for the aetiology of schizophrenia remains controversial.
Many research work reframed schizophrenia as a neurodevelop-
mental disorder [35], while other evidences in recent years suggest
that the progressive course of schizophrenia is associated with
ongoing neurodegenerative processes [36]. We considered that
CPZ may play a role in preventing the progressive deterioration
and the relapse in the course of schizophrenia by suppressing the
apoptosis.
Chlorpromazine Protects Against Apoptosis
PLoS ONE | www.plosone.org 8 July 2011 | Volume 6 | Issue 7 | e21966In conclusion, our study demonstrates that CPZ exerts a
neuroprotective effect by decreasing mitochondrially mediated
apoptosis. Although future study is necessary to determine the
molecular mechanisms underlying CPZ’s action and investigate
other potential functions of CPZ, we propose a new consideration
of CPZ as a treatment for certain chronic disorders related to
apoptosis, including brain trauma, infarction and Alzheimer’s
disease [37]. Ultimately, if clinically relevant doses and a suitable
method of administration for the prophylactic use of CPZ can be
determined, it may serve as novel approach for preventing the
apoptosis induced by exogenous stimuli.
Supporting Information
Figure S1 Schematic diagram showing how the TUNEL-
positive cells in the rat brain were counted. (A) All transverse
sections of the brain were cut at 2 mm posterior to the bregma. (B)
The slides were marked up with grid lines to separate the
section into many small squares. Total numbers of the TUNEL-
labeled cells were counted under the microscope with a hand-held
counter. The cells touching the middle line were counted on the
top and left of the squares but not on the bottom or right side.
(TIF)
Figure S2 Examples of cleaved caspase-3 scoring according to
staining intensity. (A) The expression of cleaved caspase-3 was
scored as negative=SI0, weak=SI1, intermediate=SI2, or
strong=SI3, correlating to absence of brown (that is, blue
counterstain only), light brown, brown or dark brown staining,
respectively.
(TIF)
Figure S3 CPZ pretreatment inhibits the ethanol-induced
apoptosis in thalamus of the rat brain. (A) The diagram shows
the cross section of the brain tissue, and the region of the thalamus
is pointed out. (B) TUNEL-labeled brain sections showing the
region of thalamus. These brain sections were obtained from the
following treatment groups: Saline (a, a’), Ethanol (b, b’), and CPZ
pretreatment at doses of 5 mg/kg (c, c’), 10 mg/kg (d, d’) and
20 mg/kg (e, e’). The apoptotic cells with brown nuclear staining
could be observed in the ethanol group and CPZ pretreatment +
ethanol groups. Sections were counterstained with hematoxylin.
(C) The total number of apoptotic cells throughout the whole
thalamus of each specimen was counted in three separate
experiments. Values are shown as means 6 SEM. A Mann-
Whitney U test for multiple comparisons revealed a significant
difference between the ethanol treatment group and all other
groups (***P,0.001, n=6-9 animals per group).
(TIF)
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